Document is current
Any future updates will be listed below
-
Authors
Forsby, Mathilda
Bärebring, Linnea
Amberntsson, Anna
Dangardt, Frida
Winkvist, Anna
Augustin, Hanna
-
Funding
Funding for this research was provided by:
University of Gothenburg
- License Information
-
More Information
Article History
Received: 6 November 2025
Accepted: 16 April 2026
First Online: 27 April 2026
Declarations
:
: The procedures conducted in the GraviD study were performed in accordance with the Declaration of Helsinki and had ethical approval from the Regional Ethics Committee in Gothenburg and the Swedish Ethical Review Authority (897‐11, T439‐13, T085‐14, 2019‐05219, 2021–04194, 2022–01361-02). The GraviD-Child clinical follow up is registered at ClinicalTrials.gov under the identification number NCT05228925 (Registration Date: 2021–11-18). The study information was provided in both verbal and written form. Written study information adapted to children was also provided. Written informed consent was obtained from both parents, and the participants were informed of the option of withdrawing their consent or participating in only some of the examinations.
: The authors declare no competing interests.
